Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Colombo, D.; Lunardon, L.; Bellia, G. (2014)
Publisher: Hindawi Publishing Corporation
Journal: Journal of Toxicology
Languages: English
Types: Article
Subjects: Review Article, Toxicology. Poisons, RA1190-1270, Article Subject

Classified by OpenAIRE into

mesheuropmc: food and beverages
Cyclosporine (CyA) is a well-known immunosuppressant with a narrow therapeutic window. Its bioavailability is affected by many other traditional drugs and herbal extracts. Cytochrome P-450 isoenzymes CYP3A4 and CYP3A5 and protein P-glycoprotein (P-gp) are involved in CyA bioavailability. Interactions of CyA with herbal extracts are not well known, but, given their increased concomitant use, it is important to know which extracts, many of which are commonly self-prescribed, can affect CyA blood concentrations. Decreased CyA blood concentration has been shown with St John’s wort in case reports and, in vivo animal studies, with ginger, liquorice, scutellariae radix, and quercetin. Increased CyA concentration has been reported in patients with grapefruit juice, chamomile, or berberine, and with cannabidiol or resveratrol in animal studies. Effects of Echinacea and Serenoa repens on CyA levels have not been shown consistently, but concomitant use should be avoided. Although findings from animal studies cannot be directly translated into humans, avoiding concomitant use of herbal extracts is prudent until human clinical studies have ruled out any possible interaction. Clinicians should interview their patients carefully about their use of herbal supplements before CyA administration, and those receiving CyA should be warned about possible interactions between herbal preparations and CyA.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Borel, JF. Comparative study of in vitro and in vivo drug effects on cell mediated cytotoxicity. Immunological Communications . 1976; 31 (4): 631-641
    • Kronbach, T, Fischer, V, Meyer, UA. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics . 1988; 43 (6): 630-635
    • Leveque, D, Jehl, F. P-glycoprotein and pharmacokinetics. Anticancer Research . 1995; 15 (2): 331-336
    • Wacher, VJ, Wu, C-Y, Benet, LZ. Overlapping substrate specificities and tissue distribution of cytochrome p450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Molecular Carcinogenesis . 1995; 13 (3): 129-134
    • Gaston, RS. Maintenance immunosuppression in the renal transplant recipient: an overview. American Journal of Kidney Diseases . 2001; 38 (6, supplement 6): S25-S35
    • Di, YM, Li, CG, Xue, CC, Zhou, S. Clinical drugs that interact with St. John’s wort and implication in drug development. Current Pharmaceutical Design . 2008; 14 (17): 1723-1742
    • Wentworth, JM, Agostini, M, Love, J, Schwabe, JW, Chatterjee, VKK. St John’s wort, a herbal antidepressant, activates the steroid X receptor. Journal of Endocrinology . 2000; 166 (3): R11-R16
    • Bauer, S, Störmer, E, Johne, A. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John’s wort in renal transplant patients. British Journal of Clinical Pharmacology . 2003; 55 (2): 203-211
    • Barone, GW, Gurley, BJ, Ketel, BL, Abul-Ezz, SR. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation . 2001; 71 (2): 239-241
    • Moschella, C, Jaber, BL. Interaction between cyclosporine and Hypericum perforatum (St. John’s Wort) after organ transplantation. American Journal of Kidney Diseases . 2001; 38 (5): 1105-1107
    • Bailey, DG, Spence, JD, Edgar, B, Bayliff, CD, Arnold, JMO. Ethanol enhances the hemodynamic effects of felodipine. Clinical and Investigative Medicine . 1989; 12 (6): 357-362
    • Schmiedlin-Ren, P, Edwards, DJ, Fitzsimmons, ME. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metabolism and Disposition . 1997; 25 (11): 1228-1233
    • Ducharme, MP, Warbasse, LH, Edwards, DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clinical Pharmacology and Therapeutics . 1995; 57 (5): 485-491
    • Ioannides-Demos, LL, Christophidis, N, Ryan, P, Angelis, P, Liolios, L, McLean, AJ. Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune diseases. Journal of Rheumatology . 1997; 24 (1): 49-54
    • Yee, GC, Stanley, DL, Pessa, LJ. Effect of grapefruit juice on blood cyclosporin concentration. The Lancet . 1995; 345 (8955): 955-956
    • Min, DI, Ku, Y, Perry, PJ. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation . 1996; 62 (1): 123-125
    • Brunner, LJ, Pai, K, Munar, MY, Lande, MB, Olyaei, AJ, Mowry, JA. Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients. Pediatric Transplantation . 2000; 4 (4): 313-321
    • Chiang, H, Chao, PL, Hsiu, S, Wen, K, Tsai, S, Hou, Y. Ginger significantly decreased the oral bioavailability of cyclosporine in rats. American Journal of Chinese Medicine . 2006; 34 (5): 845-855
    • Zuardi, AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Revista Brasileira de Psiquiatria . 2008; 30 (3): 271-280
    • Jaeger, W, Benet, LZ, Bornheim, LM. Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. Xenobiotica . 1996; 26 (3): 275-284
    • Budzinski, JW, Foster, BC, Vandenhoek, S, Arnason, JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine . 2000; 7 (4): 273-282
    • Goldstein, LH, Elias, M, Ron-Avraham, G. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. British Journal of Clinical Pharmacology . 2007; 64 (3): 373-380
    • Nowack, R, Nowak, B. Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrology Dialysis Transplantation . 2005; 20 (11): 2554-2556
    • Hou, YC, Lin, SP, Chao, PD. Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A. Food Chemistry . 2012; 135 (4): 2307-2312
    • Huang, B, Li, G, Ren, F. Effect of Glycyrrhiza inflata and Daphne genkwa on permeabilities of rhodamine 123, a P-glycoprotein substrate across rat jejunum membranes in vitro. Zhongguo Zhongyao Zazhi . 2008; 33 (21): 2521-2526
    • Yoshida, N, Koizumi, M, Adachi, I, Kawakami, J. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Food and Chemical Toxicology . 2006; 44 (12): 2033-2039
    • Lai, M, Hsiu, S, Hou, Y, Tsai, S, Chao, PL. Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis. Planta Medica . 2004; 70 (2): 132-137
    • Wang, Y, Chao, PL, Hsiu, S, Wen, K, Hou, Y. Lethal quercetin-digoxin interaction in pigs. Life Sciences . 2004; 74 (10): 1191-1197
    • Yang, CY, Chao, PDL, Hou, YC, Tsai, SY, Wen, KC, Hsiu, SL. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Food and Chemical Toxicology . 2006; 44 (9): 1572-1578
    • Hsiu, S, Hou, Y, Wang, Y, Tsao, C, Su, S, Chao, PL. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sciences . 2002; 72 (3): 227-235
    • Yu, C, Wu, P, Hou, Y. Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4. Journal of Agricultural and Food Chemistry . 2011; 59 (9): 4644-4648
    • Yale, SH, Glurich, I. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. Journal of Alternative and Complementary Medicine . 2005; 11 (3): 433-439
    • Hsu, PW, Shia, CS, Lin, SP. Potential risk of mulberry-drug interaction: modulation on P-glycoprotein and cytochrome P450 3A. Journal of Agricultural and Food Chemistry . 2013; 61 (18): 4464-4469
    • Mostafavi-pour, Z, Zal, F, Monabati, A, Vessal, M. Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Hepatology Research . 2008; 38 (4): 385-392
    • Zal, F, Mostafavi-Pour, Z, Vessal, M. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats. Clinical and Experimental Pharmacology and Physiology . 2007; 34 (8): 720-724
    • Satyanarayana, PSV, Singh, D, Chopra, K. Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Methods and Findings in Experimental and Clinical Pharmacology . 2001; 23 (4): 175-181
    • Regev-Shoshani, G, Shoseyov, O, Kerem, Z. Influence of lipophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4. Biochemical and Biophysical Research Communications . 2004; 323 (2): 668-673
    • Yu, L, Wu, S, Zhang, M, Pan, C. Effect of resveratrol alone and its combination with cyclosporin A on the immune function of human peripheral blood T lymphocytes. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi . 2003; 19 (6): 549-551
    • Chander, V, Tirkey, N, Chopra, K. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology . 2005; 210 (1): 55-64
    • Yang, S, Tsai, S, Hou, Y, Chao, PL. Inductive modulation on P-glycoprotein and cytochrome 3A by resveratrol, a constituent of grapes. Food Chemistry . 2012; 133 (3): 683-688
    • Tacklind, J, MacDonald, R, Rutks, I, Wilt, TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews . 2012 (12)
    • Markowitz, JS, Donovan, JL, DeVane, CL. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clinical Pharmacology and Therapeutics . 2003; 74 (6): 536-542
    • Gorski, JC, Huang, S, Pinto, A. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clinical Pharmacology and Therapeutics . 2004; 75 (1): 89-100
    • Gurley, BJ, Gardner, SF, Hubbard, MA, Williams, DK, Gentry, WB, Carrier, J. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clinical Pharmacology and Therapeutics . 2004; 76 (5): 428-440
    • Xin, H-W, Wu, X-C, Li, Q, Yu, A-R, Zhong, M-Y, Liu, Y-Y. The effects of berberine on the pharmacokinetics of ciclosporin A in healthy volunteers. Methods and Findings in Experimental and Clinical Pharmacology . 2006; 28 (1): 25-29
    • Wu, X, Li, Q, Xin, H, Yu, A, Zhong, M. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. European Journal of Clinical Pharmacology . 2005; 61 (8): 567-572
    • Pan, G, Wang, G, Liu, X, Fawcett, JP, Xie, Y. The involvement of P-glycoprotein in berberine absorption. Pharmacology and Toxicology . 2002; 91 (4): 193-197
    • Qiu, W, Jiang, XH, Liu, CX, Ju, Y, Jin, JX. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research . 2009; 23 (11): 1553-1558
    • Tsai, P, Tsai, T. Hepatobiliary excretion of berberine. Drug Metabolism and Disposition . 2004; 32 (4): 405-412
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article